Elmind Capital »

Summit Therapeutics shares owned by Elmind Capital

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Elmind Capital from 13F filings

Historical chart of Elmind Capital investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Elmind Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Elmind Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $7.2M 494k 14.57